Results 141 to 150 of about 8,463 (257)

76 Case report: use of long term aprepitant as a treatment for refractory nausea following oesophageal stent insertion [PDF]

Richard Shoulder, Joseph Taylor, Hilary Stiel   +2 more
openalex   +1 more source

Comparison of aprepitant, dexamethasone, and ondansetron with dexamethasone and ondansetron for prevention of postoperative nausea and vomiting in high-risk patients undergoing laparoscopic surgeries: a randomized controlled trial in India. [PDF]

J Minim Invasive Surg
Bala S, Meshram TM, Bhatia P, Rathod D, Kaur M, Kumari K.   +5 more
europepmc   +1 more source

A multicenter parallel-group double-blind randomized placebo-controlled phase III clinical trial of generic aprepitant QLG2174 for the prevention of postoperative nausea and vomiting

Peng Li, S Li, Wenya Du, Yanjuan Huang, 张本发, Kai Wang, Zhendong Xu, Yuanhao Qin, H Wang, Xia Xu, Shaoxing Liu, Min Zhang, Tiantian Zou, Wei Gao, Foquan Luo, Zhonghua Chen, Furong Huang, Chun Ma, Chunling Wang, Shuan Jin, Chun Chen, Jun Jing, L N Zhao, Junqing Li, Huiyu Luo, Changming Yang, Chan Wang, Yanzhuo Zhang, Xiaoling Hu, Yalan Li, Xiaoyi Ning, Yang Yan, Yunfei Ju, Yì Wáng, Mengchang Yang, Yuelan Wang, Ailin Luo   +36 more
openalex   +1 more source

Efficacy of Aprepitant in Patients with Advanced or Recurrent Lung Cancer Receiving Moderately Emetogenic Chemotherapy

, 2012
Junji Uchino, Ryosuke Hirano, Naoki Tashiro, Yūji Yoshida, Shinichiro Ushijima, Takemasa Matsumoto, Keiichi Ohta, Keita Nakatomi, Koichi Takayama, Masaki Fujita, Yoichi Nakanishi, Kentaro Watanabe   +11 more
openalex   +2 more sources

Aprepitant alleviates acute lung injury in a rat model of hepatic ischemia-reperfusion via NLRP3/IL-1β signaling pathway. [PDF]

Sci Rep
Abdelzaher WY, Kelleni MT, Adly MN, Attya ME, Fawzy MA, Ibrahim MA.   +5 more
europepmc   +1 more source

Aprepitant attenuates cutaneous mast cell migration in oxaliplatin-treated mice

Tsugunobu Andoh
openalex   +1 more source

Diagnostic and Therapeutic Potential of Substance P/NK1 Receptor in Primary Dysmenorrhea: A Pilot Study. [PDF]

Health Sci Rep
Mehboob R, Shahid I, Alzahrani AR, Yousof SM, Adnan H, Ekram SN, Alwazzan A, Nasief H, Khadawardi KA.   +8 more
europepmc   +1 more source

Three are better than two: redefining prophylaxis for postoperative nausea and vomiting. [PDF]

J Minim Invasive Surg
Kang H.
europepmc   +1 more source

Mechanism Underlying Conflicting Drug-Drug Interaction Between Aprepitant and Voriconazole via Cytochrome P450 3A4-Mediated Metabolism

Masako Ishida, Takeshi Kumagai, Tatsuro Yamamoto, Hiroyuki Suzuki, Kuniaki Moriki, Masachika Fujiyoshi, Kiyoshi Nagata, Miki Shimada   +7 more
openalex   +2 more sources

Establishing the dose of the oral NK₁ antagonist aprepitant for the prevention of chemotherapy‐induced nausea and vomiting [PDF]

, 2003
Sant P. Chawla, Steven M. Grunberg, Richard J. Gralla, Paul J. Hesketh, Cindy Rittenberg, M. Elmer, Carrie Schmidt, Arlene Taylor, Alexandra D. Carides, Judith K. Evans, Kevin Horgan   +10 more
openalex   +1 more source